International scientific community gathers in Valencia for the 9th ESWI Conference on Influenza, COVID-19, and RSV
Since it was established 30 years ago, the European Scientific Working Group on Influenza and other Acute Respiratory Viruses (ESWI) is hosting the 9TH ESWI Influenza Conference
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
This study demonstrates durable yet compartmentalised nasal IgA and plasma antibody responses to SARSCoV-2 after infection and subsequent vaccination.
WHO Europe and EPHA sign new MoU to strengthen collaboration for better health and well-being in Europe
The European Public Health Alliance have signed a memorandum of understanding with WHO Europe to enhance their partnership. Both organisations will work closely to address key health challenges and drive positive change.
The Path Towards Effective Respiratory Syncytial Virus Immunization Policies: Recommended Actions
RSV causes a substantial burden worldwide. After over six decades of research, there is finally a licensed immunization option that can protect the broad infant population, and other will follow soon.
News
Policy & Recommendations
EPHA’s priorities to strengthen public health across the EU ahead of the 2024 European elections
The European Public Health Alliance's manifesto presents five key priorities, aiming at strengthening public health and securing the EU’s resilience by working on pandemic preparedness and response.
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers
Antibody levels and neutralizing activity progressively increased with each booster but subsequently waned over 3-6 months.
United in Protection: vaccination is a show of solidarity!
Ahead of European Immunisation Week (EIW), taking place from 23 to 29 April 2023, Isabel de la Mata -principal advisor for Health and Crisis Management at the European Commission- talks about the benefits of lifelong vaccination
Changes in sleep quality and sleep disturbances in the general population from before to during the COVID-19 lockdown: A systematic review and meta-analysis
This systematic review and meta-analysis aims to explore changes in sleep quality and sleep disturbances in the general population from before to during the COVID-19 lockdown.
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study
Accurate health-care burden data in healthy infants are necessary to determine RSV immunisation policy when RSV immunisation becomes available.
|
ESWI Summit 2022: Pandemic Preparedness, Where Science and Policy Meet
ESWI pandemic preparedness summit: where science and policy meet
Main outcome of the ESWI summit “Pandemic Preparedness: Where Science and Policy Meet”, which took place in Brussels in June 2022, was recently published in the scientific journal One Health Outlook.
Estimation of the number of RSV-associated hospitalisations in adults in the European Union
RSV is a major cause of lower respiratory tract infections in older adults. Estimating RSV- associated hospitalisation is critical for planning RSV-related healthcare needs for the ageing population across Europe.
News
Reports
Policy & Recommendations
Policy priorities for protecting adults at risk of severe illness from RSV
IFA participated in the generation of a new report by the Health Policy Partnership to build awareness of the impact of RSV in adults and highlight opportunities to reduce its burden on society through appropriate prevention, diagnosis, and care.
